Clinical trial
Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi…
NCT00159016 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00159016 |
|---|---|
| Title | Role of Glivec in Patients With Tumor Cells Positive for C-kit or PDGFR; a Multi Center Study. |
| Official title | The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study. |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Novartis Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Solid Tumors. |
| Intervention type | Drug |
| Interventions | Glivec |
| Enrollment | 100 |
| Start date | Aug 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Apr 28, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: